Search - tctmd.com

Displaying 361 - 380 of 448

Sort: Relevancy | Date

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Daily News

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Industry News

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

May 20, 2015

News Industry News

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

May 20, 2015

News Industry News

Early Healing Profile Established for BioFreedom

May 20, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Yael L. Maxwell

January 28, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

Advertisement

QT Vascular wins CE Mark for drug-coated balloon

QT Vascular Announces The Allowance Of Four New Patents

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Studies Provide Encouraging Results for DCB in Long SFA Lesions

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

Early Healing Profile Established for BioFreedom

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

ISET Abstracts Shed Light on Novel Therapies for PAD

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content